September 3, 2021
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
| RegeneRx Biopharmaceuticals, Inc. Registration Statement on Form S-1 (File No. 333-258873) |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 5:00 PM on September 3, 2021 or as soon thereafter as is practicable.
RegeneRx Biopharmaceuticals, Inc. | |
/s/ J.J. Finkelstein | |
J.J. Finkelstein | |
Chief Executive Officer |